A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...
A new research paper was published in Aging (Aging-US) on January 31, 2025, in Volume 17, Issue 2, titled "Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic ...
Overall, Cysltr1 is a promising target for modulating the impact of aging on retinal tissue."BUFFALO, NY — March 25, 2025 — A new research paper was ...
Researchers have developed a groundbreaking eye drop treatment that slows vision loss in animal models of retinitis ...
A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...
Learn to spot early warning signs from your eyes that may signal serious health issues and protect your vision before it's ...
While research has determined that there is no association between having AMD and then developing Alzheimer's or dementia, ...
Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases -- SCS Microinjector® Provides ...
Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.
For a long time, it seemed like the stuff of science fiction. But with companies like Neuralink pioneering brain chips, and ...
Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.